All In MedTech

Device Trial Radar · NCT05317351

A Prospective Randomized Study Comparing the Adenoma Detection Yield of SC, AI and Combined AI and G-EYE®

A Prospective Randomized Study Comparing the Adenoma Detection Yield of (i) Standard Colonoscopy ("SC"), (ii) Artificial Intelligence (GI Genius™) ("AI"), and (Iii) Combined Artificial Intelligence (GI Genius™) and G-EYE® Colonoscopy

Last checked: Nov 20, 2026Latest source record: Apr 7, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 2,160 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,160

Planned (sponsor's estimate)

Start

May 2022

Primary completion

Dec 2022

Study completion Dec 2022

Sponsor

Lead sponsor
Smart Medical Systems Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Apr 7, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a multicenter, 3-arm, randomized, open-label study. Subjects referred to colonoscopy for screening or surveillance will be randomized in a 2:5:5 into one of the following arms: (i) Standard Colonoscopy (ii) Artificial Intelligence Aided Colonoscopy (GI Genius™) (iii) Combined Artificial Intelligence Aided Colonoscopy (GI Genius™) and G-EYE® Balloon Aided Colonoscopy

Conditions

  • Colorectal (Colon or Rectal) Cancer
  • Adenoma

Interventions

  • Standard ColonoscopyDevice

    Subjects randomized into arm 1 will undergo standard colonoscopy using a standard colonoscope

  • Artificial Intelligence Aided Colonoscopy (GI Genius™)Device

    Subjects randomized into arm 2 will undergo colonoscopy using a standard colonoscope aided by Artificial Intelligence (GI Genius™)

  • Combined Artificial Intelligence Aided Colonoscopy (GI Genius™) and G-EYE® Balloon Aided ColonoscopyDevice

    Subjects enrolled to arm 3 ("AG") will undergo colonoscopy using the G-EYE® Colonoscope and Artificial Intelligence Aided Colonoscopy (GI Genius™).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adenoma Per Colonoscopy (APC) (AI compared with AG)Time frame: Upon histology results (up to 30 days)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Indiana University

    Indianapolis, Indiana

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.